Stock Taper
SCREENER COMPARE ANY 2 STOCKS
FBRX
FORTE BIOSCIENCES, INC.
NASDAQ
$76.99
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$1.58 B
52w High$77.20
52w Low$10.11
Dividend Yield—
Frequency—
P/E-16.59
Volume0
Shares Out.20.49M

COMPANY

LEADERSHIP

Paul A. Wagner
CHIEF EXECUTIVE
Paul A. Wagner

COMPENSATION 2026

Salary$670,051
Stock Awards$0
Incentive Plan Pay$737,056
All Other Comp.$0
Total$7,358,587

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 13, 2017
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
23

PRICE TARGET

Target High$77.00
Target Low$77.00
Target Median$77.00
Target Consensus$77.00

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.—
NOV
13
FRI

SPLIT RECORD

DATETYPERATIO
2024-08-28Reverse1:25
2020-06-16Reverse1:15

PRICE

$76.99 ▲ UP 48.35% (+$73.38)
OVERLAYS
—

No price history available for FBRX over this range.

About Forte Biosciences, Inc.

https://www.fortebiorx.com ↗

Forte Biosciences, Inc., a Dallas-based clinical-stage biopharmaceutical company, is developing the FB-102 program to treat autoimmune diseases like vitiligo and alopecia areata.

INDUSTRY

Biotechnology

A PRODUCT FORTE BIOSCIENCES, INC. IS KNOWN FOR

FB102
FB102

FB102, Forte Biosciences' proprietary anti-CD122 monoclonal antibody, is in phase 2 trials for celiac disease and phase 1b trials for vitiligo and alopecia areata, targeting autoimmune diseases.

COMPETITORS

COMPETITOR
ELVN COMPARE
HROW COMPARE
PGEN COMPARE
TYRA COMPARE
ZYME COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
15
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 622.9K
ITDF
0.00% · 16

INSTITUTIONAL OWNERSHIP

SHARES OWNED
57.80%
HOLDERS
85
TOP 12 OF 85 · RANKED BY POSITION SIZE
Federated Hermes, Inc.
1.8M sh · $45.73M
Fred Alger Management, LLC
1.6M sh · $24.54M
Janus Henderson Group Plc
1.4M sh · $39.16M
Orbimed Advisors LLC
1.2M sh · $31M
Affinity Asset Advisors, LLC
1.0M sh · $26.21M
Bioimpact Capital LLC
1.0M sh · $25.92M
Adage Capital Partners Gp, L.L.C.
950.0K sh · $24.61M
Tybourne Capital Management (Hk) Ltd
786.6K sh · $11.8M
Vanguard Group Inc
582.3K sh · $15.88M
Morgan Stanley
500.3K sh · $12.96M
Cable Car Capital LLC
500.0K sh · $7.5M
Point72 Asset Management, L.P.
487.3K sh · $13.29M

INSIDER TRADES

★
DIRECTOR
VINCENT RICHARD G
Sale · 18.4K shares
2026-08-27
★
DIRECTOR
Kornfeld Steven
Sale · 800 shares
2026-08-27
★
DIRECTOR
Kornfeld Steven
Sale · 18.4K shares
2026-08-27
★
DIRECTOR
GRYSKA DAVID W
Sale · 2.0K shares
2026-08-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
EQUAL WEIGHT 1
BUY 1
2 GRADES IN THE LAST 12 MONTHS
Barclays EQUAL WEIGHT Chardan Capital BUY

SECTORS PEERS

PEERPRICE
FATE$2.48COMPARE
ALEC$2.52COMPARE
PEPG$3.15COMPARE
NKTX$2.92COMPARE
CRBP$11.22COMPARE
MOLN$4.11COMPARE
CRDF$1.08COMPARE
ELTX$2.43COMPARE